Citation

  • Authors: Sajeesh, S., Lee, T. Y., Kim, J. K., Son, D. S., Hong, S. W., Kim, S., Yun, W. S., Kim, S., Chang, C., Li, C., Lee, D. K.
  • Year: 2014
  • Journal: J Control Release 196 28-36
  • Applications: in vitro / siRNA, modified siRNA / jetPEI
  • Cell type: HeLa
    Description: Human cervix epitheloid carcinoma cells

Method

For transfection experiments, HeLa were seeded in 12-well plates and cultured for 24 h. Tripodal interfering RNA (tiRNA) structure designed to silence three known cancer targets simultaneously were used at 100 nM concentration and corresponding siRNAs, with the same targets were used as a simple mixture at the same concentration. Cells were transfected with siRNA mixture or tiRNA using jetPEI as the transfection reagent (N/P 5).

Abstract

RNA interference (RNAi) triggering oligonucleotides in unconventional structural format can offer advantages over conventional small interfering RNA (siRNA), enhanced cellular delivery and improved target gene silencing. With this concept, we present a well-defined tripodal-interfering RNA (tiRNA) structure that can induce simultaneous silencing of multiple target genes with improved potency. The tiRNA structure, formed by the complementary association of three single-stranded RNA units, was optimized for improved gene silencing efficacy. When combined with cationic polymers such as linear polyethyleneimine (PEI), tiRNA assembled to form a stable nano-structured complex through electrostatic interactions and induced stronger RNAi response over conventional siRNA-PEI complex. In combination with a liver-targeting delivery system, tripodal nucleic acid structure demonstrated enhanced fluorescent accumulation in mouse liver compared to standard duplex nucleic acid format. Tripodal RNA structure complexed with galactose-modified PEI could generate effective RNAi-mediated gene silencing effect on experimental mice models. Our studies demonstrate that optimized tiRNA structural format with appropriate polymeric carriers have immense potential to become an RNAi-based platform suitable for multi-target gene silencing.

Pubmed